{"ticker": {"uuid": "c32596a9-d7e9-4610-ac4c-781999741dc3", "symbol": "LMAT", "name": "LeMaitre Vascular Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "LeMaitre Vascular to Report Second Quarter 2026 Financial Results on August 4", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNWHZkU3A1aElMVE9meUVTYTdKZTNSeEJZNmFQZVZjY25jMkRQWjBUWVl1eHBTOVE0NVRpelV0R3BHRXVpUXJZcjhfRml1dnlEZk12OVNKVVlkbmI2QmpyeVJ3QlJncjF1ZVRObWhqRm1YNFRjWUJmSXFwbmhTekp4ZmhOQ2ZvZEZSSDAwYkIwd3EtSi1RbEEyNU5oNS05c2YzZEFsSEUzX0NoMngzQ3JF?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T21:50:00+00:00", "published_display": "14 Jul 2026 21:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026", "summary": "LeMaitre Vascular, Inc. announced it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after market close. The company will host a conference call at 5:00 PM EDT on the same day to discuss the results and outlook. Interested parties can register o", "url": "https://www.manilatimes.net/2026/07/15/tmt-newswire/globenewswire/lemaitre-will-announce-second-quarter-2026-earnings-results-on-august-4-2026/2384611", "source_name": "The Manila Times", "published_at": "2026-07-14T22:15:45", "published_display": "14 Jul 2026 22:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Schedules Aug. 4 Call to Discuss Second-Quarter Results", "summary": "LeMaitre (Nasdaq: LMAT) will release its second-quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company will host a conference call at 5:00 PM EDT on the same day to review business highlights and outlook. Investors can register online for d", "url": "https://www.stocktitan.net/news/LMAT/le-maitre-will-announce-second-quarter-2026-earnings-results-on-h95jn1a8ord0.html", "source_name": "Stock Titan", "published_at": "2026-07-14T21:15:45", "published_display": "14 Jul 2026 21:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Be Adding LeMaitre Vascular (NASDAQ:LMAT) To Your Watchlist Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNUFVuQnZvV0dSSmJrR0twSl9pMG1Jc1N3cWg4R3NBazA4UXBNc2FMWGtUQnU2RVNlUlFESk40QmhzQXZfcE1xMGduMXl1TVRKTWhvdkQyRlItaTFJMkE4WTI5aXlPTTNNUEpKNWFnM2RhS20tcUxtSU5kRnQxaE1zRS1fekZxVnNvSXlXRG40Y3oyby1EMG5rb3FnYXRyc2d1?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-09T15:04:29+00:00", "published_display": "09 Jul 2026 15:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular (NASDAQ:LMAT) Cut to \"Hold\" at Zacks Research", "summary": "Zacks Research downgraded LeMaitre Vascular (NASDAQ:LMAT) from \"strong-buy\" to \"hold\" despite a mixed to positive broader analyst view and a consensus \"Moderate Buy\" rating with a target price of $112.60. The company's stock was up 1.9% at market open, nearing its 52-week high, a", "url": "https://www.marketbeat.com/instant-alerts/lemaitre-vascular-nasdaqlmat-cut-to-hold-at-zacks-research-2026-07-08/", "source_name": "MarketBeat", "published_at": "2026-07-08T10:40:09", "published_display": "08 Jul 2026 10:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Recommendation of \"Moderate Buy\" from Analysts", "summary": "LeMaitre Vascular, Inc. (NASDAQ:LMAT) has received a consensus \"Moderate Buy\" rating from analysts, with an average 12-month price target of $112.60. The company recently reported strong quarterly results, beating earnings estimates with $0.68 per share and an 11.1% revenue incre", "url": "https://www.marketbeat.com/instant-alerts/lemaitre-vascular-inc-nasdaqlmat-receives-consensus-recommendation-of-moderate-buy-from-analysts-2026-07-07/", "source_name": "MarketBeat", "published_at": "2026-07-07T16:11:15", "published_display": "07 Jul 2026 16:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. $LMAT Shares Sold by Dividend Assets Capital LLC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNRHVoeEJZV2tqMVZrVk9BcndlNV9UUVVNbXdzS0Z2Q0NUUVVLTjNvQzhkQmZtNlZOTTNPbENnVTdfcnlTQUxUaEdMSExRT0VEaEE3MEhBY3o5Z3JNN01oUm5NNXlSaXJ2Mmpqd3lVUnU2Yi1abWJEelBZRUxfUEozSnllbk9rVTBsdHVfc3RaczQzLS1sLTVhdkJ2OXREc1BzNV8tbzBfVFctWGJqVXBFdDJzcWJHdXlVUVJKU3dCUkxpUmdtRWFjWHdR?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-06T08:39:43+00:00", "published_display": "06 Jul 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular (NASDAQ:LMAT) Upgraded to \"Buy\" at Wall Street Zen", "summary": "LeMaitre Vascular (NASDAQ:LMAT) received an upgrade from \"hold\" to \"buy\" by Wall Street Zen, contributing to a \"Moderate Buy\" consensus rating among analysts with a target price of $112.60. The company reported strong financial results, beating EPS estimates and showing an 11.1% ", "url": "https://www.marketbeat.com/instant-alerts/lemaitre-vascular-nasdaqlmat-upgraded-to-buy-at-wall-street-zen-2026-07-04/", "source_name": "MarketBeat", "published_at": "2026-07-04T05:40:34", "published_display": "04 Jul 2026 05:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. $LMAT is Conestoga Capital Advisors LLC's 7th Largest Position", "summary": "Conestoga Capital Advisors LLC increased its stake in LeMaitre Vascular (LMAT) by 3.6% in the first quarter, making it their 7th largest holding. LeMaitre Vascular reported strong quarterly earnings of $0.68 per share and an 11.1% increase in revenue. Despite mixed Wall Street vi", "url": "https://www.marketbeat.com/instant-alerts/filing-lemaitre-vascular-inc-lmat-is-conestoga-capital-advisors-llcs-7th-largest-position-2026-07-02/", "source_name": "MarketBeat", "published_at": "2026-07-02T08:12:27", "published_display": "02 Jul 2026 08:12", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. Financial Disclosures & Filings", "summary": "This page provides access to LeMaitre Vascular, Inc.'s financial disclosures and regulatory filings, including quarterly and annual earnings reports, 8-K forms, 10-Q and 10-K reports, and investor presentations. The documents span from 2021 through Q1 FY2026, offering insights in", "url": "https://www.tradingview.com/symbols/TRADEGATE-LHU/documents/", "source_name": "TradingView", "published_at": "2026-07-01T18:40:31", "published_display": "01 Jul 2026 18:40", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LMAT - Lemaitre Vascular Inc Latest SEC Filings", "summary": "This article provides a detailed financial overview and recent SEC filing information for Lemaitre Vascular Inc (LMAT). It includes current stock performance metrics, key financial ratios, insider and institutional ownership data, and various performance indicators across differe", "url": "https://finviz.com/stock?t=LMAT&ta=2&p=w&ty=lf&page=17", "source_name": "Finviz", "published_at": "2026-07-01T11:40:31", "published_display": "01 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. $LMAT Shares Sold by SG Americas Securities LLC", "summary": "SG Americas Securities LLC significantly reduced its stake in LeMaitre Vascular, Inc. by 51.3% in the first quarter, now holding 27,204 shares valued at $2.97 million. This comes as LeMaitre Vascular reported better-than-expected quarterly earnings and an 11.1% increase in revenu", "url": "https://www.marketbeat.com/instant-alerts/filing-lemaitre-vascular-inc-lmat-shares-sold-by-sg-americas-securities-llc-2026-07-01/", "source_name": "MarketBeat", "published_at": "2026-07-01T08:39:59", "published_display": "01 Jul 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of LeMaitre Vascular, Inc. \u2013 NASDAQ:LMAT", "summary": "The article focuses on the \"Price to book forward\" metric for LeMaitre Vascular, Inc., traded on NASDAQ under the symbol LMAT. It primarily presents the company's financial overview within the TradingView platform, noting that the market was closed at the time of access. The cont", "url": "https://www.tradingview.com/symbols/NASDAQ-LMAT/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T04:09:30", "published_display": "28 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. Actuals & Estimates (NASDAQ:LMAT)", "summary": "This article provides an overview of LeMaitre Vascular, Inc. (NASDAQ: LMAT) stock, including its current price, performance, and analyst forecasts. It also details financial information such as market capitalization, earnings, revenue, dividends, and employee count, alongside tec", "url": "https://www.tradingview.com/symbols/NASDAQ-LMAT/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T15:40:34", "published_display": "27 Jun 2026 15:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of LeMaitre Vascular, Inc. \u2013 NASDAQ:LMAT", "summary": "This article provides financial information for LeMaitre Vascular, Inc. (NASDAQ: LMAT), specifically focusing on its forward price to sales ratio. It lists the company on the Nasdaq Stock Market and appears to be a stub or placeholder from TradingView, indicating that detailed fi", "url": "https://www.tradingview.com/symbols/NASDAQ-LMAT/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T00:39:18", "published_display": "27 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. Actuals & Estimates (SWB:LHU)", "summary": "This article provides actuals and estimates for LeMaitre Vascular, Inc. (SWB:LHU), including financial data, analyst forecasts, and common stock information. It details the company's past earnings, revenue, net income, dividends, and offers insights into its stock performance and", "url": "https://www.tradingview.com/symbols/SWB-LHU/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T18:11:46", "published_display": "26 Jun 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular Inc (LMAT) Institutional Confidence", "summary": "LeMaitre Vascular Inc (LMAT) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. Institutional shareholding increased by 8.41% quarter-over-quarter, reaching 102.98%. The largest institutional holder is ETHSX with 27", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lmat/sentiment", "source_name": "TradingKey", "published_at": "2026-06-26T08:10:52", "published_display": "26 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LMAT Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for LeMaitre Vascular, Inc. (LMAT) stock, including its current price, analyst ratings, and financial data. It details the company's price target, EPS, revenue, and dividend information, along with offering answers to frequently asked questions ab", "url": "https://www.tradingview.com/symbols/NASDAQ-LMAT/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T05:11:46", "published_display": "26 Jun 2026 05:11", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. Actuals & Estimates (TRADEGATE:LHU)", "summary": "This article provides an overview of LeMaitre Vascular, Inc. (TRADEGATE:LHU) stock, including historical data, analyst forecasts, and financial performance. It covers details like price targets, earnings reports, revenue, net income, dividends, EBITDA, and employee numbers, along", "url": "https://www.tradingview.com/symbols/TRADEGATE-LHU/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T01:10:52", "published_display": "26 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rockefeller Capital Management L.P. Sells 100,923 Shares of LeMaitre Vascular, Inc. $LMAT", "summary": "Rockefeller Capital Management L.P. significantly reduced its stake in LeMaitre Vascular, Inc. by selling 100,923 shares, decreasing its holdings by 37.9% in the fourth quarter. Despite this, LeMaitre Vascular reported strong quarterly earnings, exceeding analyst expectations wit", "url": "https://www.marketbeat.com/instant-alerts/filing-rockefeller-capital-management-lp-sells-100923-shares-of-lemaitre-vascular-inc-lmat-2026-06-25/", "source_name": "MarketBeat", "published_at": "2026-06-25T08:40:57", "published_display": "25 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Riverbridge Partners LLC Buys Shares of 105,599 LeMaitre Vascular, Inc. $LMAT", "summary": "Riverbridge Partners LLC initiated a new position in LeMaitre Vascular, Inc., acquiring 105,599 shares valued at approximately $11.5 million in the first quarter of 2026. This investment makes Riverbridge Partners LLC one of several institutional investors increasing their stakes", "url": "https://www.marketbeat.com/instant-alerts/filing-riverbridge-partners-llc-buys-shares-of-105599-lemaitre-vascular-inc-lmat-2026-06-24/", "source_name": "MarketBeat", "published_at": "2026-06-24T10:22:01", "published_display": "24 Jun 2026 10:22", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular (LMAT) Stock Could Be 20.9% Undervalued on Its International Growth Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular (NASDAQ:LMAT) Rating Lowered to Hold at Wall Street Zen", "summary": "Wall Street Zen downgraded LeMaitre Vascular (NASDAQ:LMAT) from a \"buy\" to a \"hold\" rating, despite the broader analyst consensus remaining a \"Moderate Buy\" with an average price target of $112.60. The company recently exceeded earnings expectations with $0.68 EPS and an 11.1% in", "url": "https://www.marketbeat.com/instant-alerts/lemaitre-vascular-nasdaqlmat-rating-lowered-to-hold-at-wall-street-zen-2026-06-20/", "source_name": "MarketBeat", "published_at": "2026-06-20T05:40:34", "published_display": "20 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular Inc (LMAT) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for LeMaitre Vascular Inc (LMAT), highlighting its current earnings forecast score of 7.80, which ranks 120th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $108.00 for LMAT, with most recom", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lmat/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T07:09:30", "published_display": "18 Jun 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular Inc (LMAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of LeMaitre Vascular Inc (LMAT), detailing its price momentum score, current trading range, and technical indicator readings. It highlights that LMAT's price momentum score is 6.67, trading between a resistance level of 99.82 and a suppo", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lmat/technical", "source_name": "TradingKey", "published_at": "2026-06-18T06:41:12", "published_display": "18 Jun 2026 06:41", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular Inc (LMAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for LeMaitre Vascular Inc (LMAT), focusing on its regional revenue contributions. As of a recent update, the United States accounted for 56.72% of its revenue, followed by Other countries, Germany, Canada, and the United Kingdom. The comp", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lmat/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T01:41:12", "published_display": "18 Jun 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LMAT) Volatility Zones as Tactical Triggers", "summary": "This article analyzes Lemaitre Vascular Inc. (NASDAQ: LMAT), highlighting weak near and mid-term sentiment but a strong long-term positive outlook. It identifies key support and resistance levels, offering three distinct AI-generated trading strategies: Position Trading, Momentum", "url": "https://news.stocktradersdaily.com/news_release/78/LMAT_Volatility_Zones_as_Tactical_Triggers_061626125202_1781628722.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-16T13:10:31", "published_display": "16 Jun 2026 13:10", "sentiment": "negative", "sentiment_pct": 41, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kennedy Capital Management LLC Has $20.11 Million Stock Position in LeMaitre Vascular, Inc. $LMAT", "summary": "Kennedy Capital Management LLC increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 14.8% during the fourth quarter, now holding 247,907 shares valued at $20.1 million. Despite insider selling totaling 54,453 shares worth $5.9 million, analysts generally maintain a \"Mo", "url": "https://www.marketbeat.com/instant-alerts/filing-kennedy-capital-management-llc-has-2011-million-stock-position-in-lemaitre-vascular-inc-lmat-2026-06-14/", "source_name": "MarketBeat", "published_at": "2026-06-14T10:38:59", "published_display": "14 Jun 2026 10:38", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular declares $0.25 dividend", "summary": "LeMaitre Vascular has declared a quarterly dividend of $0.25 per share.", "url": "http://www.msn.com/en-us/health/other/lemaitre-vascular-declares-025-dividend/ar-AA22sOfB?ocid=BingNewsVerp&apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-12T19:38:59", "published_display": "12 Jun 2026 19:38", "sentiment": "positive", "sentiment_pct": 69, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of \"Moderate Buy\" by Brokerages", "summary": "LeMaitre Vascular, Inc. (NASDAQ:LMAT) has received a \"Moderate Buy\" consensus rating from eight brokerages, with an average 12-month price target of $112.60, driven by positive analyst sentiment and solid Q1 earnings that surpassed estimates. Despite recent insider selling, the c", "url": "https://www.marketbeat.com/instant-alerts/lemaitre-vascular-inc-nasdaqlmat-given-consensus-recommendation-of-moderate-buy-by-brokerages-2026-06-12/", "source_name": "MarketBeat", "published_at": "2026-06-12T08:40:10", "published_display": "12 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LMAT - Lemaitre Vascular Inc Stock Price and Quote", "summary": "This page provides a detailed overview of Lemaitre Vascular Inc. (LMAT) stock, including its latest price, financial metrics, performance indicators, analyst ratings, and recent news. It also features extensive insider trading data, showing various executives and directors engagi", "url": "https://finviz.com/stock?t=LMAT", "source_name": "Finviz", "published_at": "2026-06-12T06:11:24", "published_display": "12 Jun 2026 06:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The LeMaitre Vascular (LMAT) Story Is Shifting As Analysts Lift Fair Value Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPc19VSVZvZkt3SThYd1FqblNLMnhtZkNqOUNtclNSZ0ZiU0pvRXdNNTZfRHJpR1h3WS12ZWFVeU9zQTg0ZmkxcE45OExKTW5IRW1EUzYtR0xlZFh0TmtEOFpaclRYSVdORkVWa21GX2VUMmhtZHhnb2xpQm10Vk9MRFdHOWQyOUdpNkpqNVpfTm1halZ3ZjgwQzIxNGNZMUZRZzN0VQ?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/lemaitre-lmat-incredible-growth-stock-164502066.html", "source_name": "Zacks", "published_at": "2026-05-25T16:45:02+00:00", "published_display": "25 May 2026 16:45", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What LeMaitre Vascular (LMAT)'s Strong Quarter But Softer Guidance Means For Shareholders", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNdWNVVkxUVkRvd2tubldwelZsR3JsSkJQeFJuNUhQRjFyTlFoSGRYZkdrX0pkSHNQXzhwTXFYMjVSWDZKWUhjdmpHZ1F4N1dLVXh1Z3hqRC10Zjlfb2UtNTU5TFRxTWtFSEF5N1ZQa0tmbEdFcFBvNlhBWUZKRjdxYVR0d2xIQmxyZ1B0TGFmVW4ySkU3ejdxcHItVnBPZm9fMy12Qg?oc=5", "source_name": "Market source", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular CEO George LeMaitre sells $5.03m in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPV3lib1Nsa2JoQlJ5LUNxQ1JmQlkzaFZsZjRxaGl2OWxzN21kakpFX1AzUkh4OTZ6ZmNkdllnaDhCTHdCYms4a2JuMzNQb1FZdHlUR0ZjZFllMGp3eUpNZ0FOY2JnV2Vja3dOTWsxV1EwbzgxU0ZGeE1kcEhrdXBJamlKNFM2b0psRE1nel80c3JQZ1c2YWdVdDJtc0Rrb3RtMm1FdGFIRUpvRmNmdmpmYXJMeTdETTZ4bG5XQmZTMA?oc=5", "source_name": "Investing.com", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre management takes Bank of America conference stage May 13", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNMEQyN1NFcVpLVVJXX002ME5qQzJMa3lLRDBqdldxdDFzYll1aUpXOG9hX0NsaUpDTDZnakRpaHdNREFUWXR6MG9DQ0JFRGc0ZDBROF9WQVRuelIzYnZvSzdDdVhzM0dEbGJEdFVHSVZlSDI2aG5JV1c4WUhsV1VoVjJMc1BtZ2dmN2x6QVJBUFg3UktQZ3ZTM1lQeGU3R3dOeEFqV2xsWXZ1Xy1QWUE?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre (NASDAQ:LMAT) Posts Q1 CY2026 Sales In Line With Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPR0pHUE93eXg3eDU1eTlxT1htMmpkdkVRajRfeGpaZGR6V3hDbDJybGswd09RX1g5eHJkSGFnUEhOd3owTVQzTWM2cDR1MHptc0pXYnFiSTE0ak1qNnh2cm1TU280bmJ6THNISzR6bDhRV2g2ZGF4YmRnMGtkUG9nVmMtbC1LRDZybGJnRE42akhXZUZPT0R2bjdLVFpsRXY5R2lmUDEyVEVFTEtLZGJrTHJDb1ViVXNYVVotZUh4dFo?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre (LMAT) Q1 Earnings Report Preview: What To Look For", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOdktSOGVSNVYyVE1WU0NiQ1BDNEJjdV84UHhhOVlQaHg1ZTVCdENNcFB3b0w5MFZCMlVINGZRLWZHcUNzZm1Ycm5NU21pSVMzN01SMHh3TWhSTDdCRGdxczdYZGtIYzAtSG5mMUlLdGxZb2hOaXdFRWpXYkJqOXFuUENKNDItUUJQNWhsQmNJN3U1cmRMV21xNGtMN2oxUQ?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Buying LeMaitre Vascular (LMAT) After Its Strong Share Price Run?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPM19tR0NpdnIwaUVvdnVlZHpsaUhOX05sYy0xVno3UU4zdjdkT2dpVkwtU3RuUFlqaXBQaHVleFl3UVZoLUowSkhseGpyS0xjN0ZITUVoX2dzOUp6SUhoODh0MHhMbTN1Ny05Qm13YnFoZmd0Z2ZTeWRBaXpFc0hROE9BXzNDUVBtLUo1WTBJcTZJSnMxZEdhQ00xM0Nqbkw1SUhwaA?oc=5", "source_name": "Market source", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNWU50TkY2VVlmTmlaYlF6MFFwLWV1eEg2Ui1KWkNLZHNyS0dsbk5TWVNoUzJCUFM0NFVSTXRJeHBVR0lvQVQtUnV5WnBIb3ctMmpMbllLQTZoOGs5NGRZMnUwS2hINjl0OThXRzJpZ016UEhEQ0E3bmltX0RUWEJLTjY2Z244X3E5QVhETGtJQ3Y1UzVXX2poUWh6V2M?oc=5", "source_name": "Market source", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why The LeMaitre Vascular (LMAT) Story Is Evolving As Targets Cluster Around US$111", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOdkVhUFZaRERGdzBvcDU1TU8wUUNYOWduSkRRb2RiWmZEVGRvdVJDSGFnbTl5LThUejBOSjlkZWxTejN4djdJc3AyaXdnX095N1BzMU4xT3VKTlRjZXVvS1pOaDRFM2ROeUVFbFgxa09OMTI4SjFiR3R5Y3hvQ280Mi1qcGwzdllyaDg2X1dXeXpTZm95ZWdrdGtwR3FIdw?oc=5", "source_name": "Market source", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular Stock Surges 24% After Q4 Sales Beat. Is the $104 Street Target Still in Play?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOVWhNdmNkcGpXVXJqS3BwRnRnYnFNZjYyby01U0E4d3k1WFR6WnVEOGcyOXl1bnVyVTg1UUZGaDR6cmcxZV9xdWRpQWFzVWpxU0FZMnFwRWtiYU4taFl3ZlRrR1BNc1FKY1gtSjJhbUNkTERZUEx1WXZidTVIcmJfSVNlT3NJcFFLSzRGdFM4aDZYTnlDRm4wTGsxYUhBSFFmUGpQbWFTM0FOd1plNWsxMDltUXh3VHBTcGc?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre (LMAT) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxQOFRpRU9BdFJLdUJTYUp4bGVGTFl2TFhGbWdZUldSR3dkMXE0cERDMzZpM1lrSG9MODBucHZSbnl0NHF6d2pUY1lwYUk0ZzVfREF0TDFMdGY4UGtwaVF6SnZRa3JOWlNXcDJneUtPY09qY0JEZld5aTlLNFpZelVQU2N3?oc=5", "source_name": "Market source", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular (LMAT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE04cnlSN0F0RVhubThaVlZ6OG9fWDl0ODlNQkRFUFUtcGNFTzFGOUNEWmMxQ3FaSEZtSDI0QnNyNUhZRnEtc052QzVsQ19Ld0pXeEpVa0RVbFV3QQ?oc=5", "source_name": "MarketBeat", "published_at": "2015-06-05T14:03:50+00:00", "published_display": "05 Jun 2015 14:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "LeMaitre Vascular to Report Second Quarter 2026 Financial Results on August 4", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNWHZkU3A1aElMVE9meUVTYTdKZTNSeEJZNmFQZVZjY25jMkRQWjBUWVl1eHBTOVE0NVRpelV0R3BHRXVpUXJZcjhfRml1dnlEZk12OVNKVVlkbmI2QmpyeVJ3QlJncjF1ZVRObWhqRm1YNFRjWUJmSXFwbmhTekp4ZmhOQ2ZvZEZSSDAwYkIwd3EtSi1RbEEyNU5oNS05c2YzZEFsSEUzX0NoMngzQ3JF?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-14T21:50:00+00:00", "published_display": "14 Jul 2026 21:50", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026", "summary": "LeMaitre Vascular, Inc. announced it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after market close. The company will host a conference call at 5:00 PM EDT on the same day to discuss the results and outlook. Interested parties can register o", "url": "https://www.manilatimes.net/2026/07/15/tmt-newswire/globenewswire/lemaitre-will-announce-second-quarter-2026-earnings-results-on-august-4-2026/2384611", "source_name": "The Manila Times", "published_at": "2026-07-14T22:15:45", "published_display": "14 Jul 2026 22:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Schedules Aug. 4 Call to Discuss Second-Quarter Results", "summary": "LeMaitre (Nasdaq: LMAT) will release its second-quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company will host a conference call at 5:00 PM EDT on the same day to review business highlights and outlook. Investors can register online for d", "url": "https://www.stocktitan.net/news/LMAT/le-maitre-will-announce-second-quarter-2026-earnings-results-on-h95jn1a8ord0.html", "source_name": "Stock Titan", "published_at": "2026-07-14T21:15:45", "published_display": "14 Jul 2026 21:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should You Be Adding LeMaitre Vascular (NASDAQ:LMAT) To Your Watchlist Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxNUFVuQnZvV0dSSmJrR0twSl9pMG1Jc1N3cWg4R3NBazA4UXBNc2FMWGtUQnU2RVNlUlFESk40QmhzQXZfcE1xMGduMXl1TVRKTWhvdkQyRlItaTFJMkE4WTI5aXlPTTNNUEpKNWFnM2RhS20tcUxtSU5kRnQxaE1zRS1fekZxVnNvSXlXRG40Y3oyby1EMG5rb3FnYXRyc2d1?oc=5", "source_name": "\u5bcc\u9014\u725b\u725b", "published_at": "2026-07-09T15:04:29+00:00", "published_display": "09 Jul 2026 15:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular (NASDAQ:LMAT) Cut to \"Hold\" at Zacks Research", "summary": "Zacks Research downgraded LeMaitre Vascular (NASDAQ:LMAT) from \"strong-buy\" to \"hold\" despite a mixed to positive broader analyst view and a consensus \"Moderate Buy\" rating with a target price of $112.60. The company's stock was up 1.9% at market open, nearing its 52-week high, a", "url": "https://www.marketbeat.com/instant-alerts/lemaitre-vascular-nasdaqlmat-cut-to-hold-at-zacks-research-2026-07-08/", "source_name": "MarketBeat", "published_at": "2026-07-08T10:40:09", "published_display": "08 Jul 2026 10:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Recommendation of \"Moderate Buy\" from Analysts", "summary": "LeMaitre Vascular, Inc. (NASDAQ:LMAT) has received a consensus \"Moderate Buy\" rating from analysts, with an average 12-month price target of $112.60. The company recently reported strong quarterly results, beating earnings estimates with $0.68 per share and an 11.1% revenue incre", "url": "https://www.marketbeat.com/instant-alerts/lemaitre-vascular-inc-nasdaqlmat-receives-consensus-recommendation-of-moderate-buy-from-analysts-2026-07-07/", "source_name": "MarketBeat", "published_at": "2026-07-07T16:11:15", "published_display": "07 Jul 2026 16:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. $LMAT Shares Sold by Dividend Assets Capital LLC", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNRHVoeEJZV2tqMVZrVk9BcndlNV9UUVVNbXdzS0Z2Q0NUUVVLTjNvQzhkQmZtNlZOTTNPbENnVTdfcnlTQUxUaEdMSExRT0VEaEE3MEhBY3o5Z3JNN01oUm5NNXlSaXJ2Mmpqd3lVUnU2Yi1abWJEelBZRUxfUEozSnllbk9rVTBsdHVfc3RaczQzLS1sLTVhdkJ2OXREc1BzNV8tbzBfVFctWGJqVXBFdDJzcWJHdXlVUVJKU3dCUkxpUmdtRWFjWHdR?oc=5", "source_name": "MarketBeat", "published_at": "2026-07-06T08:39:43+00:00", "published_display": "06 Jul 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular (NASDAQ:LMAT) Upgraded to \"Buy\" at Wall Street Zen", "summary": "LeMaitre Vascular (NASDAQ:LMAT) received an upgrade from \"hold\" to \"buy\" by Wall Street Zen, contributing to a \"Moderate Buy\" consensus rating among analysts with a target price of $112.60. The company reported strong financial results, beating EPS estimates and showing an 11.1% ", "url": "https://www.marketbeat.com/instant-alerts/lemaitre-vascular-nasdaqlmat-upgraded-to-buy-at-wall-street-zen-2026-07-04/", "source_name": "MarketBeat", "published_at": "2026-07-04T05:40:34", "published_display": "04 Jul 2026 05:40", "sentiment": "positive", "sentiment_pct": 77, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. $LMAT is Conestoga Capital Advisors LLC's 7th Largest Position", "summary": "Conestoga Capital Advisors LLC increased its stake in LeMaitre Vascular (LMAT) by 3.6% in the first quarter, making it their 7th largest holding. LeMaitre Vascular reported strong quarterly earnings of $0.68 per share and an 11.1% increase in revenue. Despite mixed Wall Street vi", "url": "https://www.marketbeat.com/instant-alerts/filing-lemaitre-vascular-inc-lmat-is-conestoga-capital-advisors-llcs-7th-largest-position-2026-07-02/", "source_name": "MarketBeat", "published_at": "2026-07-02T08:12:27", "published_display": "02 Jul 2026 08:12", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. Financial Disclosures & Filings", "summary": "This page provides access to LeMaitre Vascular, Inc.'s financial disclosures and regulatory filings, including quarterly and annual earnings reports, 8-K forms, 10-Q and 10-K reports, and investor presentations. The documents span from 2021 through Q1 FY2026, offering insights in", "url": "https://www.tradingview.com/symbols/TRADEGATE-LHU/documents/", "source_name": "TradingView", "published_at": "2026-07-01T18:40:31", "published_display": "01 Jul 2026 18:40", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LMAT - Lemaitre Vascular Inc Latest SEC Filings", "summary": "This article provides a detailed financial overview and recent SEC filing information for Lemaitre Vascular Inc (LMAT). It includes current stock performance metrics, key financial ratios, insider and institutional ownership data, and various performance indicators across differe", "url": "https://finviz.com/stock?t=LMAT&ta=2&p=w&ty=lf&page=17", "source_name": "Finviz", "published_at": "2026-07-01T11:40:31", "published_display": "01 Jul 2026 11:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. $LMAT Shares Sold by SG Americas Securities LLC", "summary": "SG Americas Securities LLC significantly reduced its stake in LeMaitre Vascular, Inc. by 51.3% in the first quarter, now holding 27,204 shares valued at $2.97 million. This comes as LeMaitre Vascular reported better-than-expected quarterly earnings and an 11.1% increase in revenu", "url": "https://www.marketbeat.com/instant-alerts/filing-lemaitre-vascular-inc-lmat-shares-sold-by-sg-americas-securities-llc-2026-07-01/", "source_name": "MarketBeat", "published_at": "2026-07-01T08:39:59", "published_display": "01 Jul 2026 08:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of LeMaitre Vascular, Inc. \u2013 NASDAQ:LMAT", "summary": "The article focuses on the \"Price to book forward\" metric for LeMaitre Vascular, Inc., traded on NASDAQ under the symbol LMAT. It primarily presents the company's financial overview within the TradingView platform, noting that the market was closed at the time of access. The cont", "url": "https://www.tradingview.com/symbols/NASDAQ-LMAT/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T04:09:30", "published_display": "28 Jun 2026 04:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. Actuals & Estimates (NASDAQ:LMAT)", "summary": "This article provides an overview of LeMaitre Vascular, Inc. (NASDAQ: LMAT) stock, including its current price, performance, and analyst forecasts. It also details financial information such as market capitalization, earnings, revenue, dividends, and employee count, alongside tec", "url": "https://www.tradingview.com/symbols/NASDAQ-LMAT/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T15:40:34", "published_display": "27 Jun 2026 15:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of LeMaitre Vascular, Inc. \u2013 NASDAQ:LMAT", "summary": "This article provides financial information for LeMaitre Vascular, Inc. (NASDAQ: LMAT), specifically focusing on its forward price to sales ratio. It lists the company on the Nasdaq Stock Market and appears to be a stub or placeholder from TradingView, indicating that detailed fi", "url": "https://www.tradingview.com/symbols/NASDAQ-LMAT/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T00:39:18", "published_display": "27 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. Actuals & Estimates (SWB:LHU)", "summary": "This article provides actuals and estimates for LeMaitre Vascular, Inc. (SWB:LHU), including financial data, analyst forecasts, and common stock information. It details the company's past earnings, revenue, net income, dividends, and offers insights into its stock performance and", "url": "https://www.tradingview.com/symbols/SWB-LHU/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T18:11:46", "published_display": "26 Jun 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular Inc (LMAT) Institutional Confidence", "summary": "LeMaitre Vascular Inc (LMAT) has an institutional shareholding score of 10.00, placing it first in the Healthcare Equipment & Supplies industry. Institutional shareholding increased by 8.41% quarter-over-quarter, reaching 102.98%. The largest institutional holder is ETHSX with 27", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lmat/sentiment", "source_name": "TradingKey", "published_at": "2026-06-26T08:10:52", "published_display": "26 Jun 2026 08:10", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LMAT Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for LeMaitre Vascular, Inc. (LMAT) stock, including its current price, analyst ratings, and financial data. It details the company's price target, EPS, revenue, and dividend information, along with offering answers to frequently asked questions ab", "url": "https://www.tradingview.com/symbols/NASDAQ-LMAT/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T05:11:46", "published_display": "26 Jun 2026 05:11", "sentiment": "positive", "sentiment_pct": 62, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. Actuals & Estimates (TRADEGATE:LHU)", "summary": "This article provides an overview of LeMaitre Vascular, Inc. (TRADEGATE:LHU) stock, including historical data, analyst forecasts, and financial performance. It covers details like price targets, earnings reports, revenue, net income, dividends, EBITDA, and employee numbers, along", "url": "https://www.tradingview.com/symbols/TRADEGATE-LHU/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T01:10:52", "published_display": "26 Jun 2026 01:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rockefeller Capital Management L.P. Sells 100,923 Shares of LeMaitre Vascular, Inc. $LMAT", "summary": "Rockefeller Capital Management L.P. significantly reduced its stake in LeMaitre Vascular, Inc. by selling 100,923 shares, decreasing its holdings by 37.9% in the fourth quarter. Despite this, LeMaitre Vascular reported strong quarterly earnings, exceeding analyst expectations wit", "url": "https://www.marketbeat.com/instant-alerts/filing-rockefeller-capital-management-lp-sells-100923-shares-of-lemaitre-vascular-inc-lmat-2026-06-25/", "source_name": "MarketBeat", "published_at": "2026-06-25T08:40:57", "published_display": "25 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Riverbridge Partners LLC Buys Shares of 105,599 LeMaitre Vascular, Inc. $LMAT", "summary": "Riverbridge Partners LLC initiated a new position in LeMaitre Vascular, Inc., acquiring 105,599 shares valued at approximately $11.5 million in the first quarter of 2026. This investment makes Riverbridge Partners LLC one of several institutional investors increasing their stakes", "url": "https://www.marketbeat.com/instant-alerts/filing-riverbridge-partners-llc-buys-shares-of-105599-lemaitre-vascular-inc-lmat-2026-06-24/", "source_name": "MarketBeat", "published_at": "2026-06-24T10:22:01", "published_display": "24 Jun 2026 10:22", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular (LMAT) Stock Could Be 20.9% Undervalued on Its International Growth Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular (NASDAQ:LMAT) Rating Lowered to Hold at Wall Street Zen", "summary": "Wall Street Zen downgraded LeMaitre Vascular (NASDAQ:LMAT) from a \"buy\" to a \"hold\" rating, despite the broader analyst consensus remaining a \"Moderate Buy\" with an average price target of $112.60. The company recently exceeded earnings expectations with $0.68 EPS and an 11.1% in", "url": "https://www.marketbeat.com/instant-alerts/lemaitre-vascular-nasdaqlmat-rating-lowered-to-hold-at-wall-street-zen-2026-06-20/", "source_name": "MarketBeat", "published_at": "2026-06-20T05:40:34", "published_display": "20 Jun 2026 05:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular Inc (LMAT) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "This article provides an earnings forecast for LeMaitre Vascular Inc (LMAT), highlighting its current earnings forecast score of 7.80, which ranks 120th in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $108.00 for LMAT, with most recom", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lmat/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T07:09:30", "published_display": "18 Jun 2026 07:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular Inc (LMAT) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of LeMaitre Vascular Inc (LMAT), detailing its price momentum score, current trading range, and technical indicator readings. It highlights that LMAT's price momentum score is 6.67, trading between a resistance level of 99.82 and a suppo", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lmat/technical", "source_name": "TradingKey", "published_at": "2026-06-18T06:41:12", "published_display": "18 Jun 2026 06:41", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular Inc (LMAT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a revenue breakdown for LeMaitre Vascular Inc (LMAT), focusing on its regional revenue contributions. As of a recent update, the United States accounted for 56.72% of its revenue, followed by Other countries, Germany, Canada, and the United Kingdom. The comp", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-lmat/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T01:41:12", "published_display": "18 Jun 2026 01:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(LMAT) Volatility Zones as Tactical Triggers", "summary": "This article analyzes Lemaitre Vascular Inc. (NASDAQ: LMAT), highlighting weak near and mid-term sentiment but a strong long-term positive outlook. It identifies key support and resistance levels, offering three distinct AI-generated trading strategies: Position Trading, Momentum", "url": "https://news.stocktradersdaily.com/news_release/78/LMAT_Volatility_Zones_as_Tactical_Triggers_061626125202_1781628722.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-16T13:10:31", "published_display": "16 Jun 2026 13:10", "sentiment": "negative", "sentiment_pct": 41, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Kennedy Capital Management LLC Has $20.11 Million Stock Position in LeMaitre Vascular, Inc. $LMAT", "summary": "Kennedy Capital Management LLC increased its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 14.8% during the fourth quarter, now holding 247,907 shares valued at $20.1 million. Despite insider selling totaling 54,453 shares worth $5.9 million, analysts generally maintain a \"Mo", "url": "https://www.marketbeat.com/instant-alerts/filing-kennedy-capital-management-llc-has-2011-million-stock-position-in-lemaitre-vascular-inc-lmat-2026-06-14/", "source_name": "MarketBeat", "published_at": "2026-06-14T10:38:59", "published_display": "14 Jun 2026 10:38", "sentiment": "positive", "sentiment_pct": 60, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular declares $0.25 dividend", "summary": "LeMaitre Vascular has declared a quarterly dividend of $0.25 per share.", "url": "http://www.msn.com/en-us/health/other/lemaitre-vascular-declares-025-dividend/ar-AA22sOfB?ocid=BingNewsVerp&apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-12T19:38:59", "published_display": "12 Jun 2026 19:38", "sentiment": "positive", "sentiment_pct": 69, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular, Inc. (NASDAQ:LMAT) Given Consensus Recommendation of \"Moderate Buy\" by Brokerages", "summary": "LeMaitre Vascular, Inc. (NASDAQ:LMAT) has received a \"Moderate Buy\" consensus rating from eight brokerages, with an average 12-month price target of $112.60, driven by positive analyst sentiment and solid Q1 earnings that surpassed estimates. Despite recent insider selling, the c", "url": "https://www.marketbeat.com/instant-alerts/lemaitre-vascular-inc-nasdaqlmat-given-consensus-recommendation-of-moderate-buy-by-brokerages-2026-06-12/", "source_name": "MarketBeat", "published_at": "2026-06-12T08:40:10", "published_display": "12 Jun 2026 08:40", "sentiment": "positive", "sentiment_pct": 67, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LMAT - Lemaitre Vascular Inc Stock Price and Quote", "summary": "This page provides a detailed overview of Lemaitre Vascular Inc. (LMAT) stock, including its latest price, financial metrics, performance indicators, analyst ratings, and recent news. It also features extensive insider trading data, showing various executives and directors engagi", "url": "https://finviz.com/stock?t=LMAT", "source_name": "Finviz", "published_at": "2026-06-12T06:11:24", "published_display": "12 Jun 2026 06:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The LeMaitre Vascular (LMAT) Story Is Shifting As Analysts Lift Fair Value Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPc19VSVZvZkt3SThYd1FqblNLMnhtZkNqOUNtclNSZ0ZiU0pvRXdNNTZfRHJpR1h3WS12ZWFVeU9zQTg0ZmkxcE45OExKTW5IRW1EUzYtR0xlZFh0TmtEOFpaclRYSVdORkVWa21GX2VUMmhtZHhnb2xpQm10Vk9MRFdHOWQyOUdpNkpqNVpfTm1halZ3ZjgwQzIxNGNZMUZRZzN0VQ?oc=5", "source_name": "Market source", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/lemaitre-lmat-incredible-growth-stock-164502066.html", "source_name": "Zacks", "published_at": "2026-05-25T16:45:02+00:00", "published_display": "25 May 2026 16:45", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What LeMaitre Vascular (LMAT)'s Strong Quarter But Softer Guidance Means For Shareholders", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Winners And Losers Of Q1: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNdWNVVkxUVkRvd2tubldwelZsR3JsSkJQeFJuNUhQRjFyTlFoSGRYZkdrX0pkSHNQXzhwTXFYMjVSWDZKWUhjdmpHZ1F4N1dLVXh1Z3hqRC10Zjlfb2UtNTU5TFRxTWtFSEF5N1ZQa0tmbEdFcFBvNlhBWUZKRjdxYVR0d2xIQmxyZ1B0TGFmVW4ySkU3ejdxcHItVnBPZm9fMy12Qg?oc=5", "source_name": "Market source", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular CEO George LeMaitre sells $5.03m in stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxPV3lib1Nsa2JoQlJ5LUNxQ1JmQlkzaFZsZjRxaGl2OWxzN21kakpFX1AzUkh4OTZ6ZmNkdllnaDhCTHdCYms4a2JuMzNQb1FZdHlUR0ZjZFllMGp3eUpNZ0FOY2JnV2Vja3dOTWsxV1EwbzgxU0ZGeE1kcEhrdXBJamlKNFM2b0psRE1nel80c3JQZ1c2YWdVdDJtc0Rrb3RtMm1FdGFIRUpvRmNmdmpmYXJMeTdETTZ4bG5XQmZTMA?oc=5", "source_name": "Investing.com", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre management takes Bank of America conference stage May 13", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNMEQyN1NFcVpLVVJXX002ME5qQzJMa3lLRDBqdldxdDFzYll1aUpXOG9hX0NsaUpDTDZnakRpaHdNREFUWXR6MG9DQ0JFRGc0ZDBROF9WQVRuelIzYnZvSzdDdVhzM0dEbGJEdFVHSVZlSDI2aG5JV1c4WUhsV1VoVjJMc1BtZ2dmN2x6QVJBUFg3UktQZ3ZTM1lQeGU3R3dOeEFqV2xsWXZ1Xy1QWUE?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-07T07:00:00+00:00", "published_display": "07 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre (NASDAQ:LMAT) Posts Q1 CY2026 Sales In Line With Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxPR0pHUE93eXg3eDU1eTlxT1htMmpkdkVRajRfeGpaZGR6V3hDbDJybGswd09RX1g5eHJkSGFnUEhOd3owTVQzTWM2cDR1MHptc0pXYnFiSTE0ak1qNnh2cm1TU280bmJ6THNISzR6bDhRV2g2ZGF4YmRnMGtkUG9nVmMtbC1LRDZybGJnRE42akhXZUZPT0R2bjdLVFpsRXY5R2lmUDEyVEVFTEtLZGJrTHJDb1ViVXNYVVotZUh4dFo?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre (LMAT) Q1 Earnings Report Preview: What To Look For", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOdktSOGVSNVYyVE1WU0NiQ1BDNEJjdV84UHhhOVlQaHg1ZTVCdENNcFB3b0w5MFZCMlVINGZRLWZHcUNzZm1Ycm5NU21pSVMzN01SMHh3TWhSTDdCRGdxczdYZGtIYzAtSG5mMUlLdGxZb2hOaXdFRWpXYkJqOXFuUENKNDItUUJQNWhsQmNJN3U1cmRMV21xNGtMN2oxUQ?oc=5", "source_name": "Market source", "published_at": "2026-05-04T07:00:00+00:00", "published_display": "04 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider Buying LeMaitre Vascular (LMAT) After Its Strong Share Price Run?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPM19tR0NpdnIwaUVvdnVlZHpsaUhOX05sYy0xVno3UU4zdjdkT2dpVkwtU3RuUFlqaXBQaHVleFl3UVZoLUowSkhseGpyS0xjN0ZITUVoX2dzOUp6SUhoODh0MHhMbTN1Ny05Qm13YnFoZmd0Z2ZTeWRBaXpFc0hROE9BXzNDUVBtLUo1WTBJcTZJSnMxZEdhQ00xM0Nqbkw1SUhwaA?oc=5", "source_name": "Market source", "published_at": "2026-04-19T07:00:00+00:00", "published_display": "19 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is LeMaitre Vascular, Inc. (LMAT) A Good Stock To Buy Now?", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNWU50TkY2VVlmTmlaYlF6MFFwLWV1eEg2Ui1KWkNLZHNyS0dsbk5TWVNoUzJCUFM0NFVSTXRJeHBVR0lvQVQtUnV5WnBIb3ctMmpMbllLQTZoOGs5NGRZMnUwS2hINjl0OThXRzJpZ016UEhEQ0E3bmltX0RUWEJLTjY2Z244X3E5QVhETGtJQ3Y1UzVXX2poUWh6V2M?oc=5", "source_name": "Market source", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why The LeMaitre Vascular (LMAT) Story Is Evolving As Targets Cluster Around US$111", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOdkVhUFZaRERGdzBvcDU1TU8wUUNYOWduSkRRb2RiWmZEVGRvdVJDSGFnbTl5LThUejBOSjlkZWxTejN4djdJc3AyaXdnX095N1BzMU4xT3VKTlRjZXVvS1pOaDRFM2ROeUVFbFgxa09OMTI4SjFiR3R5Y3hvQ280Mi1qcGwzdllyaDg2X1dXeXpTZm95ZWdrdGtwR3FIdw?oc=5", "source_name": "Market source", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular Stock Surges 24% After Q4 Sales Beat. Is the $104 Street Target Still in Play?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOVWhNdmNkcGpXVXJqS3BwRnRnYnFNZjYyby01U0E4d3k1WFR6WnVEOGcyOXl1bnVyVTg1UUZGaDR6cmcxZV9xdWRpQWFzVWpxU0FZMnFwRWtiYU4taFl3ZlRrR1BNc1FKY1gtSjJhbUNkTERZUEx1WXZidTVIcmJfSVNlT3NJcFFLSzRGdFM4aDZYTnlDRm4wTGsxYUhBSFFmUGpQbWFTM0FOd1plNWsxMDltUXh3VHBTcGc?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-27T08:00:00+00:00", "published_display": "27 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre (LMAT) Stock Trades Up, Here Is Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMiggFBVV95cUxQOFRpRU9BdFJLdUJTYUp4bGVGTFl2TFhGbWdZUldSR3dkMXE0cERDMzZpM1lrSG9MODBucHZSbnl0NHF6d2pUY1lwYUk0ZzVfREF0TDFMdGY4UGtwaVF6SnZRa3JOWlNXcDJneUtPY09qY0JEZld5aTlLNFpZelVQU2N3?oc=5", "source_name": "Market source", "published_at": "2026-02-26T08:00:00+00:00", "published_display": "26 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "LeMaitre Vascular (LMAT) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE04cnlSN0F0RVhubThaVlZ6OG9fWDl0ODlNQkRFUFUtcGNFTzFGOUNEWmMxQ3FaSEZtSDI0QnNyNUhZRnEtc052QzVsQ19Ld0pXeEpVa0RVbFV3QQ?oc=5", "source_name": "MarketBeat", "published_at": "2015-06-05T14:03:50+00:00", "published_display": "05 Jun 2015 14:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 86, "total_relevant": 45, "sentiment_summary": {"positive": 21, "negative": 2, "neutral": 22, "score": 58, "total": 45, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 74, "events": [{"event": "general", "label": "Market update", "weight": 10.25, "count": 18}, {"event": "earnings", "label": "Earnings", "weight": 9.9, "count": 18}, {"event": "analyst", "label": "Analyst action", "weight": 3.3, "count": 6}, {"event": "capital_return", "label": "Capital return", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 21, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 102.74, "latest_week": "2026-07-10", "one_week_move": -0.1, "four_week_move": 11.7, "twelve_week_move": -9.9, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": -0.371811, "market_dynamics_buy_signal": false, "relative_strength": -5.803706, "fair_value_gap": 26.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 52.3176, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.1% over one week, +11.7% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 56, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "MarketBeat", "count": 12}, {"label": "TradingView", "count": 7}, {"label": "Market source", "count": 7}, {"label": "TradingKey", "count": 4}, {"label": "Stock Titan", "count": 2}, {"label": "Finviz", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Quiver Quantitative", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 45}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 18}, {"label": "Market update", "count": 18}, {"label": "Analyst action", "count": 6}, {"label": "Capital return", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "58/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "74/100 classification confidence."}, {"label": "Company focus", "value": "45", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-0.1% over one week, +11.7% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "LeMaitre Vascular to Report Second Quarter 2026 Financial Results on August 4"}], "updated_at": "2026-07-16T00:50:49.261161+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}